pristiq Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Pristiq, and what generic alternatives are available?

Pristiq is a drug marketed by Pf Prism Cv and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has twenty-two patent family members in sixteen countries.

The generic ingredient in PRISTIQ is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pristiq

A generic version of pristiq was approved as desvenlafaxine succinate by ALEMBIC on June 29^th, 2015.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for pristiq?
What are the global sales for pristiq?
What is Average Wholesale Price for pristiq?

Summary for pristiq

International Patents:	22
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	53
Clinical Trials:	23
Patent Applications:	50
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for pristiq
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for pristiq
What excipients (inactive ingredients) are in pristiq?	pristiq excipients list
DailyMed Link:	pristiq at DailyMed

Drug patent expirations by year for pristiq

Recent Clinical Trials for pristiq

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
David Steffens	Phase 4
National Institute of Mental Health (NIMH)	Phase 4
Korea Cancer Center Hospital	Phase 4

See all pristiq clinical trials

Pharmacology for pristiq

Drug Class	Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of Action	Cytochrome P450 2D6 Inhibitors Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors

Paragraph IV (Patent) Challenges for PRISTIQ

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
PRISTIQ	Extended-release Tablets	desvenlafaxine succinate	25 mg	021992	1	2015-05-08
PRISTIQ	Extended-release Tablets	desvenlafaxine succinate	50 mg and 100 mg	021992	12	2012-02-29

US Patents and Regulatory Information for pristiq

pristiq is protected by one US patents.

Patents protecting pristiq

Derivatives of venlafaxine and methods of preparing and using the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-003	Aug 20, 2014	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-001	Feb 29, 2008	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-002	Feb 29, 2008	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for pristiq

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-002	Feb 29, 2008	⤷ Sign Up	⤷ Sign Up
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-003	Aug 20, 2014	⤷ Sign Up	⤷ Sign Up
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-001	Feb 29, 2008	⤷ Sign Up	⤷ Sign Up
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-002	Feb 29, 2008	⤷ Sign Up	⤷ Sign Up
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-001	Feb 29, 2008	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for pristiq

See the table below for patents covering pristiq around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Germany	60039132		⤷ Sign Up
Eurasian Patent Organization	011451	НОВАЯ СОЛЬ СУКЦИНАТ О-ДЕСМЕТИЛВЕНЛАФАКСИНА (NOVEL SUCCINATE SALT OF O-DESMETHYL-VENLAFAXINE)	⤷ Sign Up
European Patent Office	1905757		⤷ Sign Up
China	100567253		⤷ Sign Up
Australia	782092		⤷ Sign Up
Portugal	1360169		⤷ Sign Up
Mexico	PA03007043	NUEVA SAL DE SUCCINATO DE O-DESMETIL-VENLAFAXINA. (NOVEL SUCCINATE SALT OF O-DESMETHYL-VENLAFAXINE.)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration